Risk of diabetes mellitus in long-term survivors of Hodgkin lymphoma

Journal of Clinical Oncology

Volumn 32, Issue 29, 2014, Pages 3257-3263

  Van Nimwegen, Frederika A ^a   Schaapveld, Michael ^a,b   Janus, Cecile P M ^d   Krol, Augustinus D G ^e   Raemaekers, John M M ^f,g   Kremer, Leontien C M ^c   Stovall, Marilyn ^h   Aleman, Berthe M P ^a   Van Leeuwen, Flora E ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b Comprehensive Cancer Centre the Netherlands ^*  (United States)

^c EMMA CHILDREN S HOSPITAL   (Netherlands)

^d ERASMUS MC CANCER INSTITUTE   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g RIJNSTATE HOSPITAL   (Netherlands)

^h UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVOR; CLINICAL TRIAL; DIABETES MELLITUS; DOSIMETRY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; INCIDENCE; INFRADIAPHRAGMATIC RADIOTHERAPY; IRRADIATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PARA AORTIC LYMPH NODE IRRADIATION; SPLEEN IRRADIATION; LYMPH NODE; PANCREAS; RADIATION DOSE; RADIATION RESPONSE; REGRESSION ANALYSIS; RISK FACTOR; SURVIVOR;

ADULT; DIABETES MELLITUS; FEMALE; HODGKIN DISEASE; HUMANS; INCIDENCE; LYMPH NODES; MALE; PANCREAS; RADIOTHERAPY DOSAGE; REGRESSION ANALYSIS; RISK FACTORS; SURVIVORS;

EID: 84907519664     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.54.4379     Document Type: Article

References (42)

1. Integraal Kankercentrum Nederland: Dutch Cancer Figures. Amsterdam, the Netherlands, Association of Comprehensive Cancer Centers, 2012
2. Borchmann P, Eichenauer DA, Engert A: State of the art in the treatment of Hodgkin lymphoma. Nat Rev Clin Oncol 9:450-459, 2012
3. Aleman BM, van den Belt-Dusebout AW, De Bruin ML, et al: Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 109:1878-1886, 2007
4. De Bruin ML, Dorresteijn LD, van't Veer MB, et al: Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst 101:928-937, 2009
5. Hodgson DC, Gilbert ES, Dores GM, et al: Longterm solid cancer risk among 5-year survivors of Hodgkin's lymphoma. J Clin Oncol 25:1489-1497, 2007
6. Ng AK: Review of the cardiac long-term effects of therapy for Hodgkin lymphoma. Br J Haematol 154:23-31, 2011
7. Swerdlow AJ, Higgins CD, Smith P, et al: Myocardial infarction mortality risk after treatment for Hodgkin disease: A collaborative British cohort study. J Natl Cancer Inst 99:206-214, 2007
8. Castellino SM, Geiger AM, Mertens AC, et al: Morbidity and mortality in long-term survivors of Hodgkin lymphoma: A report from the Childhood Cancer Survivor Study. Blood 117:1806-1816, 2011
9. Swerdlow AJ, Higgins CD, Smith P, et al: Second cancer risk after chemotherapy for Hodgkin's lymphoma: A collaborative British cohort study. J Clin Oncol 29:4096-4104, 2011
10. van Leeuwen FE, Klokman WJ, Veer MB, et al: Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood. J Clin Oncol 18:487-497, 2000
11. Meacham LR, Sklar CA, Li S, et al: Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: A report for the childhood cancer survivor study. Arch Intern Med 169:1381-1388, 2009
12. de Vathaire F, El-Fayech C, Ben Ayed FF, et al: Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: A retrospective cohort study. Lancet Oncol 13:1002-1010, 2012
13. Gaede P, Vedel P, Larsen N, et al: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 348:383-393, 2003
14. Kannel WB, McGee DL: Diabetes and cardiovascular disease: The Framingham study. JAMA 241:2035-2038, 1979
15. Stamler J, Vaccaro O, Neaton JD, et al: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
16. Armstrong GT, Liu Q, Yasui Y, et al: Late mortality among 5-year survivors of childhood cancer: A summary from the Childhood Cancer Survivor Study. J Clin Oncol 27:2328-2338, 2009
17. Lenihan DJ, Cardinale DM: Late cardiac effects of cancer treatment. J Clin Oncol 30:3657-3664, 2012
18. Hancock SL, Tucker MA, Hoppe RT: Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 270:1949-1955, 1993
19. van Leeuwen FE, Klokman WJ, Hagenbeek A, et al: Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol 12:312-325, 1994
20. De Bruin ML, Burgers JA, Baas P, et al: Malignant mesothelioma after radiation treatment for Hodgkin lymphoma. Blood 113:3679-3681, 2009
21. Carde P, Burgers JM, Henry-Amar M, et al: Clinical stages I and II Hodgkin's disease: A specifically tailored therapy according to prognostic factors. J Clin Oncol 6:239-252, 1988
22. Eghbali H, Raemaekers J, Carde P, et al: The EORTC strategy in the treatment of Hodgkin's lymphoma. Eur J Haematol 75:135-140, 2005 (suppl 66)
23. Raemaekers J, Kluin-Nelemans H, Teodorovic I, et al: The achievements of the EORTC Lymphoma Group: European Organisation for Research and Treatment of Cancer. Eur J Cancer 38:S107-S113, 2002
24. Somers R, Tubiana M, Henry-Amar M: EORTC Lymphoma Cooperative Group studies in clinical stage I-II Hodgkin's disease 1963-1987. Recent Results Cancer Res 117:175-181, 1989
25. Tubiana M, Henry-Amar M, Carde P, et al: Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease: The EORTC Lymphoma Group controlled clinical trials-1964-1987. Blood 73:47-56, 1989
26. Morton LM, Dores GM, Curtis RE, et al: Stomach cancer risk after treatment for Hodgkin lymphoma. J Clin Oncol 31:3369-3377, 2013
27. Gooley TA, Leisenring W, Crowley J, et al: Estimation of failure probabilities in the presence of competing risks: New representations of old estimators. Stat Med 18:695-706, 1999
28. NIVEL Primary Care Database. http://www.nivel.nl/en/dossier/nivel-primary-care-database
29. Neville KA, Cohn RJ, Steinbeck KS, et al: Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: Prevalence and risk factors. J Clin Endocrinol Metab 91:4401-4407, 2006
30. Taskinen M, Saarinen-Pihkala UM, Hovi L, et al: Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 356:993-997, 2000
31. Traggiai C, Stanhope R, Nussey S, et al: Diabetes mellitus after bone marrow transplantation during childhood. Med Pediatr Oncol 40:128-129, 2003
32. Lorini R, Cortona L, Scaramuzza A, et al: Hyperinsulinemia in children and adolescents after bone marrow transplantation. Bone Marrow Transplant 15:873-877, 1995
33. Alberti KG, Zimmet P, Shaw J: The metabolic syndrome: A new worldwide definition. Lancet 366:1059-1062, 2005
34. Nuver J, Smit AJ, Postma A, et al: The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures. Cancer Treat Rev 28:195-214, 2002
35. Baker KS, Chow E, Steinberger J: Metabolic syndrome and cardiovascular risk in survivors after hematopoietic cell transplantation. Bone Marrow Transplant 47:619-625, 2012
36. Bosco D, Armanet M, Morel P, et al: Unique arrangement of alpha- and beta-cells in human islets of Langerhans. Diabetes 59:1202-1210, 2010
37. Du Toit DF, Heydenrych JJ, Smit B, et al: The effect of ionizing radiation on the primate pancreas: An endocrine and morphologic study. J Surg Oncol 34:43-52, 1987
38. Teinturier C, Tournade MF, Caillat-Zucman S, et al: Diabetes mellitus after abdominal radiation therapy. Lancet 346:633-634, 1995
39. Cicognani A, Cacciari E, Mancini AF, et al: Abnormal insulin response to glucose following treatment for Wilms' tumor in childhood. Eur J Pediatr 156:371-375, 1997
40. Oeffinger KC, Sklar CA: Abdominal radiation and diabetes: One more piece in the puzzle. Lancet Oncol 13:961-962, 2012
41. Adams MJ, Lipsitz SR, Colan SD, et al: Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 22:3139-3148, 2004
42. Tukenova M, Guibout C, Oberlin O, et al: Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer. J Clin Oncol 28:1308-1315, 2010.